Cardinal Health projects 'cliff' then sales rebound after losing large Rx customer

The contract made up 17% of revenue for Cardinal's pharmaceutical distribution segment, but just 4% of the segment's operating profit.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news